Genetic Architecture of Complex Traits

Multiple Factor Hypothesis: The Genetic Architecture Behind Quantitative Traits in Crop Breeding What is the Multiple Factor Hypothesis? Proposed by Herman Nilsson-Ehle (1909), it states that: Quantitative traits are controlled by many genes (polygenes), each contributing a small, additive effect. The concept introduced by (1909), and later expanded through classical quantitative genetics frameworks articulated by and , fundamentally bridged Mendelian inheritance with continuous variation observed in agronomic traits. The Multiple Factor Hypothesis posits that complex traits are governed by numerous loci, each contributing small, predominantly additive effects. 🌾 Relevance to Crop Breeding Most traits of economic importance—grain yield, abiotic stress tolerance, resource-use efficiency, and quality parameters—exhibit polygenic inheritance. Their phenotypic expression reflects the cumulative contribution of multiple genes along with environmental modulation. Conceptual Representation For a simple case with two gene pairs: Phenotype = G_1 + G_2 + E Where: � = effects of different genes � = environmental influence This explains why traits show a normal distribution in populations. 🔬 Implications for Breeding Strategy 1. Additive Genetic Variance as the Primary Driver The hypothesis underscores the central role of additive gene action, which forms the basis of: Response to selection Predictability of breeding outcomes Long-term genetic gain 2. Foundation of Quantitative Genetics It provides the theoretical framework for: Partitioning phenotypic variance Estimating heritability Designing effective selection schemes 3. Selection Methodologies Breeding approaches such as: Recurrent selection Mass and family selection Genomic selection derive their effectiveness from the cumulative fixation of favorable alleles across loci. 4. Interpretation of Continuous Variation The characteristic normal distribution of phenotypes in segregating populations is a direct outcome of multi-locus control, enabling: Selection of superior transgressive segregants Incremental improvement across cycles 5. Integration with Modern Genomics Contemporary tools—QTL mapping, GWAS, and genomic prediction—do not replace this hypothesis; rather, they operationalize it at higher resolution, enabling the identification and utilization of small-effect loci across the genome. 🌍 Concluding Perspective Despite rapid advances in gene editing and molecular breeding, the fundamental architecture of most agronomic traits remains polygenic. Sustained genetic gain in crop improvement is achieved not through single major-effect loci alone, but through the systematic accumulation and optimization of numerous small-effect alleles. #QuantitativeGenetics #PlantBreeding #GeneticGain #PolygenicTraits #CropImprovement #GenomicSelection #AgriculturalScience

🧬 Your DNA Has a Shadow Network 🥷 We used to imagine gene regulation as straightforward: one gene, one promoter, one switch. Flip it on, and transcription begins. Simple, right? Not even close. 🔍 In reality, the expression of a single gene can be orchestrated by multiple regulatory elements, some located thousands of base pairs away. These include enhancers, silencers, and insulators that don’t sit right next to the gene, but still have powerful influence. 🧠 These elements fold and loop through 3D space, creating a complex regulatory network where multiple regions of the genome come together to fine-tune a gene’s output. It’s not linear, it’s architectural. This explains: 🧬 How the same gene behaves differently in brain cells vs. liver cells ⚠️ Why mutations far from a gene’s coding region can still lead to disease 🧪 How subtle regulatory tweaks shape development, plasticity, and evolution The video by Smart Biology shows this complexity in action — gene expression as choreography, not command. #GeneRegulation #Biology #DNA #Genomics

New research shows one genetic marker links 8 major psychiatric disorders — including autism, ADHD, schizophrenia, and depression. A groundbreaking study has identified 683 common genetic variants that link eight major psychiatric conditions, including autism, ADHD, schizophrenia, and major depressive disorder. These shared genetic factors appear to regulate critical stages of brain development and influence complex protein interactions, providing a biological explanation for why these conditions frequently co-occur within individuals and families. This discovery suggests that rather than being entirely distinct ailments, many mental health disorders share a foundational genetic architecture that shapes the brain's growth from its earliest stages. By shifting the focus from individual diagnoses to shared biological pathways, this research challenges traditional psychiatric classifications and opens the door for innovative, broad-spectrum therapies. With nearly one billion people worldwide living with mental health disorders, the ability to target these underlying genetic drivers could revolutionize treatment protocols. Scientists believe that understanding these shared variants will lead to more effective, genetically-informed interventions that could simultaneously address multiple conditions, offering new hope for personalized and comprehensive mental healthcare. Source: Psychiatric Genomics Consortium. Shared genetic architectures across psychiatric disorders and brain development. Cell.

One of the most important lessons I ever received in psychopharmacology came from a professor who said, almost casually: “Genes do not encode disease. They encode function. Disease is a byproduct of functional systems operating under constraint.” From a systems and evolutionary perspective, that statement is exactly right. Yet biomedical discourse still frames genetics in linear causal terms—“risk genes,” “cancer genes,” “autism genes,” “genes for Alzheimer’s.” The accompanying narrative assumes a fragile organism whose biological “errors” are simply waiting for environmental “triggers.” This framing persists because it is simple, not because it is accurate. When viewed through the Evolutionary-Stress Framework—integrating allostasis, predictive processing, and complex-systems physiology—a more coherent interpretation emerges: 1. Genes specify functional capacities, not pathologies. They regulate energy allocation, sensory precision, metabolic efficiency, learning biases, and stress responsivity. These are adaptive in context. 2. Disease states emerge when functional systems exceed their energetic constraints. High-precision, high-sensitivity, high-plasticity phenotypes carry significant metabolic costs. Under stable conditions these costs are compensated; under instability they accumulate. 3. What we call “vulnerability” is often a sentinel phenotype. High-information processors, including many neuroperipheral profiles, detect environmental perturbations earlier and respond more intensely. This amplification is functional—it is an attempt to preserve coherence within the system—but it carries trade-offs. 4. Environmental mismatch increases allostatic load, not because the genes are weak, but because the environment is unstable. Disease emerges not from defective machinery but from constrained energy budgets, chronic unpredictability, and intercepted allostatic regulation. This reframing dissolves the old binary of “genes vs. environment” and replaces it with an integrated model: genetic architectures create functional strategies; stress landscapes determine whether those strategies remain stable or collapse into pathology-like states. In other words: Outcomes do not start with fragility. They start with functional strengths running beyond their metabolic limits. This is a more scientifically precise narrative—and a far more humane one.

Multiple Genes and Human Disease: Polygenic, Oligogenic and Stratagenic. Implications for Precision Medicine. In this informative Nature Portfolio Genetics article, the authors “discuss and contrast three conceptual models developed to explain how multigenic risk is generated. The polygenic model, derived from the century-old infinitesimal model, has been the dominant framework for understanding the genetic inheritance of complex traits. More recently, two mechanistic models have been proposed: the omnigenic model, which hypothesizes core genes with direct effects on disease and peripheral genes with regulatory, indirect effects, and what we call the ‘stratagenic’ model, in which the genetic risk of disease is stratified across genomic pathways of functional relevance. There are key differences in the implications of these models for research, drug development and precision medicine.” https://lnkd.in/ehSANgyi

NotebookLM: "...massively parallel reporter assays (MPRA) [were used] to systematically evaluate the functional impact of over 200,000 genetic variants associated with complex human diseases and molecular traits. By testing these variants across diverse cell types, the researchers identified over 13,000 trait-associated regulatory variants (TARVs) that directly modulate gene expression, providing a high-precision map of the non-coding genome. The authors employed saturation mutagenesis to achieve single-nucleotide resolution, uncovering that many causal variants operate through non-canonical mechanisms or complex interactions that traditional models often overlook. Ultimately, the work reveals a sophisticated regulatory grammar where multiple variants can interact epistatically within the same element to dampen or amplify genetic risk. This comprehensive framework bridges the gap between statistical associations found in large-scale biobanks and the specific molecular mechanisms that drive human health and disease." "... a massive database of 4.3 million common genetic variants found across 233 primate species [was employed] to improve the diagnosis of human diseases. Because humans and primates are closely related, mutations that are harmless in monkeys or apes are likely benign in humans as well. By cataloging these tolerated variations, researchers were able to reclassify millions of human mutations that were previously of unknown clinical significance. To analyze the remaining data, the team developed PrimateAI-3D, a deep learning model that utilizes 3D protein structures to predict whether mutations are pathogenic. This artificial intelligence outperformed existing methods in identifying disease-causing variants in large patient groups, including those with neurodevelopmental disorders. Ultimately, the study demonstrates how evolutionary history and advanced technology can work together to realize the promise of personalized genomic medicine." file:///Users/kenwasserman/Downloads/s41586-026-10121-6-1.pdf https://lnkd.in/e5cB3xYM listen to the podcast: https://lnkd.in/ei-k8MYb

The genetics of hypertension — where are we in 2026? Outstanding Review Article in Nature Reviews Nephrology (2026) summarizing how hypertension emerges from the complex interplay between: rare variants with large effects (monogenic hypertension) common variants with small effects (polygenic hypertension) epigenetic regulation and environmental modifiers Key takeaways: Blood pressure heritability is estimated at 30–50% Most monogenic forms of hypertension involve renal sodium handling Somatic mutations in hormone-producing tumours (aldosterone, cortisol, catecholamines) represent a key model of secondary hypertension Many genes implicated in Mendelian disease and GWAS are already targets of current antihypertensive drugs — others may become future therapeutic targets Bottom line: understanding the genetic architecture of hypertension is no longer just biology — it is the foundation for risk stratification, precision medicine, and next-generation antihypertensive therapies. Highly recommended reading for anyone working in hypertension, nephrology, or cardiovascular risk. https://lnkd.in/dMAvSMXH #Hypertension #Genetics #PrecisionMedicine #CardiovascularRisk #Nephrology #Aldosterone #ResistantHypertension

Excited to see our work published in the Journal of Applied Physiology this week. Here's a breakdown of the paper. Some people enter Basic Combat Training (BCT) with bones that are better prepared for the load than others. We see a lot (~6-8%) of bone stress injuries. There are a ton of factors that go into that. Some of it is training history. Some of it is nutrition. And some of it may be written, very faintly, in the genome. In our new paper, we looked at genetic risk scores and tibial bone microarchitecture in 2,550 U.S. Army trainees going through BCT. A genetic risk score is a way to combine many small genetic differences into a broader estimate of inherited predisposition. Most single genetic variants do very little on their own. One SNP may nudge bone density slightly higher or lower, but usually not enough to explain the outcome alone. A genetic risk score adds up several of these variants, often based on prior genome-wide association studies, to ask a more practical question: Does a person carry more alleles that have previously been linked to lower (in this case) bone density, fracture risk, vitamin D status, or bone remodeling pathways? We found 47 significant associations between bone-related genetic risk scores (GRS) and baseline bone microarchitecture at the distal tibia. The Adult-GRS was generally associated with lower volumetric bone mineral density, lower trabecular density, and lower bone volume. The Fracture-GRS, Pediatric-GRS, RANK-GRS, and WNT-GRS also showed relationships with specific trabecular or cortical bone traits. These were not huge effects. Most explained a small percentage of the variance (2- 6%). But that is exactly what we would expect for complex traits like bone microarchitecture. No variable explains the whole system. On the other hand, vitamin D-related SNPs and the vitamin D genetic risk score were not associated with bone properties at baseline or changes in bone during training. Interestingly, the vitamin D GRS did relate to baseline vitamin D status, but that genetic predisposition did not translate into differences in bone microarchitecture during BCT. Take home: Genetic risk scores may be more useful for identifying who enters training with less favorable skeletal characteristics than for predicting who adapts over 10 weeks of intense loading... we already take blood at MEPS - why not use it for a few more things? Genetics will not replace other factors, but it may help us understand why two people can complete the same training and have different outcomes. This paper was a HUGE team effort. Thank you for all who contributed. It could not be done without you. Jessie Hendricks; @Katelyn Guerriere Aaron; Leila Walker; Cara S., Alyssa Geddis; Katie Taylor; James McClung, STEPHEN FOULIS, Julie Hughes, Martha Petrovick, @Erin Gaffney-Stomberg American Physiological Society APS EEP Section

🌱𝗠𝗲𝗻𝗱𝗲𝗹𝗶𝘇𝗶𝗻𝗴 𝗤𝗧𝗟𝘀 𝗜𝗜: 𝗜𝗻𝘁𝗿𝗼𝗴𝗿𝗲𝘀𝘀𝗶𝗼𝗻 𝗟𝗶𝗻𝗲𝘀 𝗳𝗼𝗿 𝗖𝗼𝗻𝘃𝗲𝗿𝘁𝗶𝗻𝗴 𝗠𝗶𝗻𝗼𝗿 𝗤𝗧𝗟𝘀 𝘁𝗼 𝗠𝗮𝗷𝗼𝗿🌱 This post continues the topic from my previous article, where I explained the importance of 𝗺𝗲𝗻𝗱𝗲𝗹𝗶𝘇𝗶𝗻𝗴 𝗤𝗧𝗟𝘀 to drive stronger genetic gains in breeding programs. Here, I want to show how relatively complex genetic tools, like 𝗜𝗻𝘁𝗿𝗼𝗴𝗿𝗲𝘀𝘀𝗶𝗼𝗻 𝗟𝗶𝗻𝗲𝘀 (𝗜𝗟𝘀), work exceptionally well in this process—allowing minor QTLs to express clearly and behave like major ones. 🔬𝗪𝗵𝗮𝘁 𝗔𝗿𝗲 𝗜𝗻𝘁𝗿𝗼𝗴𝗿𝗲𝘀𝘀𝗶𝗼𝗻 𝗟𝗶𝗻𝗲𝘀? 𝗜𝗻𝘁𝗿𝗼𝗴𝗿𝗲𝘀𝘀𝗶𝗼𝗻 𝗟𝗶𝗻𝗲𝘀 (𝗜𝗟𝘀) are plant lines where small chromosomal segments from a donor parent are systematically introduced into the genetic background of an elite cultivar. Each IL typically carries one specific segment, allowing breeders and geneticists to study the effect of individual QTLs without the noise of other varying loci. In simpler terms: ILs turn complex backgrounds into manageable experiments, helping isolate and study QTLs one by one. 🧬 𝗛𝗼𝘄 𝗜𝗟𝘀 𝗛𝗲𝗹𝗽 𝗠𝗲𝗻𝗱𝗲𝗹𝗶𝘇𝗲 𝗤𝗧𝗟𝘀 By fixing individual QTLs in a uniform background, ILs "mendelize" complex traits: 𝗠𝗶𝗻𝗼𝗿 𝗤𝗧𝗟𝘀, which might otherwise be hidden by background noise, become visible and selectable. Researchers can 𝘀𝘁𝗮𝗰𝗸 𝗺𝘂𝗹𝘁𝗶𝗽𝗹𝗲 𝗯𝗲𝗻𝗲𝗳𝗶𝗰𝗶𝗮𝗹 𝗤𝗧𝗟𝘀 in controlled ways. This precision allows breeders to transform quantitative traits into more predictable, Mendelian-like inheritance patterns. Fixed ILs also allow us to study 𝗲𝗽𝗶𝘀𝘁𝗮𝘀𝗶𝘀—the interactions between QTLs—by combining different ILs and observing the resulting phenotypes. 🌟𝗖𝗮𝘀𝗲 𝗦𝘁𝘂𝗱𝘆: 𝗦𝘁𝗮𝗰𝗸𝗶𝗻𝗴 𝗤𝗧𝗟𝘀 𝘁𝗼 𝗕𝗼𝗼𝘀𝘁 𝗬𝗶𝗲𝗹𝗱 𝗮𝗻𝗱 𝗕𝗿𝗶𝘅 𝗶𝗻 𝗧𝗼𝗺𝗮𝘁𝗼 An excellent example of this approach comes from a study where three independent QTLs were pyramided to improve Brix × Yield (BXY) in tomato. Researchers selected a 𝘁𝗿𝗶𝗽𝗹𝗲-𝘀𝘁𝗮𝗰𝗸 𝗼𝗳 𝗤𝗧𝗟𝘀 and created an "immortalized F2" population using marker-assisted selection. Although most QTL–QTL interactions showed less-than-additive effects, the triple-stack displayed a truly additive effect, outperforming the standard elite variety M82. Importantly, this immortalized F2 now serves as a permanent resource for breeding programs—a building block of superior taste and yield that can be introgressed into other elite materials, accelerating the creation of even more competitive varieties. 🔗https://lnkd.in/dHXFHsCn 🚀 𝗙𝗶𝗻𝗮𝗹 𝗧𝗵𝗼𝘂𝗴𝗵𝘁𝘀 When properly integrated into the breeding process, introgression lines are a powerful accelerator of genetic gains. They allow us to: 👍Expose hidden genetic potential, 👍Study complex genetic interactions clearly, 👍Build new donors carrying stacks of desirable QTLs. Building tools like ILs isn’t about complexity for its own sake—it’s about achieving real, measurable results for breeding programs. #QTLs#AgroSynapsis#MendelianTrait

More about Genetic modifiers, now in a brilliant Cell article explaining variable expressivity of a complex disorder Phenotypic variability associated with disease-linked primary variants is substantially driven by the genetic background of the individual, with secondary variants exhibiting modifier effects that are specific to the primary variant, population, and disease context. Analyzing 2,455 individuals with primary variants across diverse cohorts—including those with 16p12.1 deletion and other variants like 16p11.2 deletion and CHD8 variants—researchers demonstrated that the phenotypic associations are highly dependent on the synergistic interaction between primary and secondary variants. Specifically, within the 16p12.1 deletion cohort, distinct rare and common secondary variant classes (e.g., short tandem repeats) were linked to specific neurodevelopmental features, and these associations, along with the underlying biological pathways, were shown to be sensitive to the cohort ascertainment method. The study in Cell https://lnkd.in/ekvAZhZd concludes that dissecting the heterogeneous clinical features of complex disorders requires a comprehensive assessment of the full spectrum of secondary variants in multiple contexts, providing a paradigm for understanding the personalized genomic architecture of these conditions. #genetics #genomics #precisionmedicine #genomicmedicine #brain #neurology #neuroscience #neurodegeneration #neuroinflammation #inflammation #immunity #aging #longevity #cognition #alzheimer #parkinson #movementdisorders #raredisease #dementia #autism #geroscience #lysosomalstoragedisease #psychiatry #neurodevelopment #neurogenesis #metabolism #lysosome #mitochondria #autophagy #omics #lipids #lipidomics #cellbiology #microbiome #regenerativemedicine #environment #pollution  #publichealth #physiology #biobank #health #drugs #drugrepurposing #drugdiscovery #drugdevelopment #biomarkers #therapeutics #biotechnology #innovation #research #science #sciencecommunication